Australia markets closed

Gamida Cell Ltd. (GMDA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.7300-0.0400 (-2.26%)
As of 01:49PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 104.97M
Enterprise value 114.60M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.20
Enterprise value/revenue N/A
Enterprise value/EBITDA -1.32

Trading information

Stock price history

Beta (5Y monthly) 1.82
52-week change 3-71.99%
S&P500 52-week change 3-13.03%
52-week high 36.4100
52-week low 31.6700
50-day moving average 32.2638
200-day moving average 33.1215

Share statistics

Avg vol (3-month) 3735.93k
Avg vol (10-day) 3290.5k
Shares outstanding 559.98M
Implied shares outstanding 6N/A
Float 838.3M
% held by insiders 130.14%
% held by institutions 129.49%
Shares short (14 June 2022) 42.81M
Short ratio (14 June 2022) 49.56
Short % of float (14 June 2022) 45.60%
Short % of shares outstanding (14 June 2022) 44.68%
Shares short (prior month 12 May 2022) 43.04M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-33.05%
Return on equity (ttm)-166.84%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -86.94M
Net income avi to common (ttm)-90.83M
Diluted EPS (ttm)-1.5310
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)69.72M
Total cash per share (mrq)1.16
Total debt (mrq)79.34M
Total debt/equity (mrq)317.58
Current ratio (mrq)3.55
Book value per share (mrq)0.42

Cash flow statement

Operating cash flow (ttm)-86.64M
Levered free cash flow (ttm)-61.67M